Which serologic test for celiac disease has the highest specificity?

Which serologic test for celiac disease has the highest specificity?

• A. Tissue transglutaminase (tTG) IgA antibody
• B. Deamidated gliadin peptide antibodies
• C. Anti-gliadin antibodies
• D. Anti-endomysial antibody

Answer: (D)

In serologic testing for celiac disease, specificity is how well a test correctly identifies people who do not have the disease. The anti-endomysial antibody test has the highest specificity among common celiac serologies, approaching nearly perfect levels. It’s detected by indirect immunofluorescence on a tissue substrate, and the staining pattern it produces is highly specific for celiac disease, so a positive result strongly supports the diagnosis and helps distinguish true cases from false positives. Other tests balance sensitivity and specificity differently. Tissue transglutaminase IgA (tTG IgA) is the most widely used screening test because it detects most true cases (high sensitivity) with good specificity, but it isn’t as specific as EMA. Deamidated gliadin peptide antibodies improve on older anti-gliadin tests, offering better accuracy but still not matching EMA’s specificity. Anti-gliadin antibodies have relatively poor specificity due to cross-reactivity with other conditions, making them the least reliable for confirming disease. Keep in mind EMA testing uses IgA and can be false-negative in IgA deficiency, in which case IgG-based testing is used.

In serologic testing for celiac disease, specificity is how well a test correctly identifies people who do not have the disease. The anti-endomysial antibody test has the highest specificity among common celiac serologies, approaching nearly perfect levels. It’s detected by indirect immunofluorescence on a tissue substrate, and the staining pattern it produces is highly specific for celiac disease, so a positive result strongly supports the diagnosis and helps distinguish true cases from false positives.

Other tests balance sensitivity and specificity differently. Tissue transglutaminase IgA (tTG IgA) is the most widely used screening test because it detects most true cases (high sensitivity) with good specificity, but it isn’t as specific as EMA. Deamidated gliadin peptide antibodies improve on older anti-gliadin tests, offering better accuracy but still not matching EMA’s specificity. Anti-gliadin antibodies have relatively poor specificity due to cross-reactivity with other conditions, making them the least reliable for confirming disease.

Keep in mind EMA testing uses IgA and can be false-negative in IgA deficiency, in which case IgG-based testing is used.